Sajid A Khan, MD, FACS, FSSO

Sajid Khan, MD is an Associate Professor of Surgery (Oncology), Chief of Hepato-Pancreato-Biliary & Mixed Tumors, and Co-Director of Team Science at Yale School of Medicine. Dr. Khan is internationally recognized for superb clinical care and excellence in cancer research. He earned his medical degree from SUNY Upstate Medical University in Syracuse, NY and is Board Certified in both Complex General Surgical Oncology and General Surgery. He completed general surgery training at Oregon Health & Science University in Portland, OR and Albert Einstein College of Medicine/Montefiore in Bronx, NY. He also completed a research fellowship in surgical oncology at Memorial Sloan-Kettering Cancer Center in New York, NY and a clinical and research fellowship in surgical oncology at University of Chicago Medical Center in Chicago, IL. Watch a video with Dr. Sajid Khan >>. Dr. Khan is dedicated to improving the lives of cancer patients by his busy surgical practice, federally funded research, leadership by example, and kindness.

Dr. Khan's complex surgical oncology practice specializes in patients with tumors of the liver, pancreas, bile ducts, stomach, and colon. Additionally he treats individuals diagnosed with melanoma and neuroendocrine tumors. He has performed over 1,600 oncologic surgeries throughout the Yale Health System. His commitment to his patients and their families incorporates a multidisciplinary team approach, excellent communication, and minimally invasive surgery to provide an exceptional patient experience. Nationally, he has been named Top Doctors by Castle Connolly and consistently is in top percentile ranks for patient satisfaction. At the Yale Cancer Center, he is Co-Leader of the Advanced Hepatobiliary Disease Program and Co-Director of the Hepatic Arterial Infusion Pump Program.

Dr. Khan is a federally funded, well published, surgeon-scientist who uses modern molecular biology (focused on metabolomics and transcriptomics) to improve society's understanding and treatment of patients with gastrointestinal cancers. His surgical oncology wet and dry lab research program has been consistently funded by the National Institutes of Health/National Cancer Institute (R01s, R21s, KL2) and incorporates principles of team science. The Khan Lab performs translational research exploring the scientific underpinnings of liver metastasis, developing biomarkers for pancreas cancer, and identifying novel genomic pathways which are drivers of cancer development. In addition, the Khan Lab studies the relationship of tumor metabolites and RNA expression with race/ethnicity and sex. He also performs clinical outcomes research for all types of gastrointestinal cancers. His lab’s research is regularly presented at national and international scientific meetings, has >100 publications in prestigious scientific journals, and is featured in national media outlets.

Dr. Khan is Chair of the Society of Surgery of the Alimentary Tract (SSAT) Research Committee, on the Editorial Board for the Annals of Surgical Oncology and Indian Journal of Surgery, and Institutional Representative for the Society of University Surgeons (SUS). He is an active member of the Society of Surgery of the Alimentary Tract (SSAT), Society of Surgical Oncology (SSO), Society of University Surgeons (SUS), Surgical Biology Club (SBC), National Comprehensive Cancer Center (NCCN), American College of Surgeons (ACS), Association for Academic Surgery (AAS), Southwest Oncology Group (SWOG), American Society of Clinical Oncology (ASCO), Yale Center for Clinical Investigation (YCCI), and Yale Cancer Center.